Recent advances in the research and management of sepsis-associated DIC

Int J Hematol. 2021 Jan;113(1):24-33. doi: 10.1007/s12185-020-03053-y. Epub 2021 Jan 2.

Abstract

Disseminated intravascular coagulation (DIC) is a common and life-threatening complication in sepsis. Sepsis-associated DIC is recognized as the systemic activation in coagulation with suppressed fibrinolysis that leads to organ dysfunction in combination with systemic intravascular inflammation. In this process, thrombin contributes a key role in connecting both coagulation and inflammation. Endothelial injury, a result of sepsis, causes DIC due to the effect of multiple activated factors that include neutrophils, platelets, and damage-associated molecular patterns. Recent advances in the understanding of pathophysiology have made it possible to diagnose sepsis-associated DIC at earlier timing with better accuracy. However, progress in the treatment is still limited, and new therapeutics for sepsis-associated DIC are needed.

Keywords: Coagulopathy; Disseminated intravascular blood coagulation; Endothelial cell; Fibrinolysis.

Publication types

  • Review

MeSH terms

  • Blood Platelets
  • Disseminated Intravascular Coagulation / blood*
  • Disseminated Intravascular Coagulation / diagnosis
  • Disseminated Intravascular Coagulation / etiology*
  • Early Diagnosis
  • Endothelial Cells
  • Fibrinolysis
  • Humans
  • Inflammation
  • Neutrophils
  • Prognosis
  • Sepsis / complications*
  • Thrombin / physiology

Substances

  • Thrombin